No Common Ground

Regarding the news article in the May 30, 1994, issue of The Scientist reporting on the perennial animal research debate [N. Sankaran, page 3]: Any new panel, at any level, official or nonofficial, is doomed to failure, since no common ground exists for discussion between researchers and animal rights activists. The quote by John McArdle, scientific adviser to the Jenkintown, Pa.-based American Anti-Vivisection Society- -"The ultima

Written byFrederick Sperling
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Regarding the news article in the May 30, 1994, issue of The Scientist reporting on the perennial animal research debate [N. Sankaran, page 3]: Any new panel, at any level, official or nonofficial, is doomed to failure, since no common ground exists for discussion between researchers and animal rights activists. The quote by John McArdle, scientific adviser to the Jenkintown, Pa.-based American Anti-Vivisection Society- -"The ultimate goal is to replace animals with other methods, since we believe it is immoral and unethical to use animals"--plainly indicates that a rational discussion is impossible and agreement with the activists is wishful thinking.

I pointed this out at a National Institutes of Health conference a few years ago. It is just as true now as it was then. That conference degenerated into name-calling and personal attacks by the animal rights participants. No agreement of any kind was reached.

I personally resent being characterized ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies